Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1AURORE PHARMACEUTICALS PRIVATE LIMITED
03 1Dasami Lab Private Limited
04 1Fagron Inc
05 1Glenmark Life Sciences Limited
06 1LETCO MEDICAL, LLC
07 1MYLAN LABORATORIES LIMITED
08 1Medisca Inc.
09 1Piramal Pharma Limited
10 1Professional Compounding Centers of America
11 1Professional Compounding Centers of America dba PCCA
12 1RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
13 1Spectrum Laboratory Products, Inc.
14 2Tianish Laboratories Private Limited
01 6VERAPAMIL HYDROCHLORIDE
02 1Verapamil
03 2Verapamil Hcl
04 6Verapamil Hydrochloride
01 6India
02 1Italy
03 1Netherlands
04 5U.S.A
05 2United Kingdom
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-132
Start Marketing Date : 2020-07-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (480kg/480kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51552-0525
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-02-02
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1161
Start Marketing Date : 2009-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0275
Start Marketing Date : 2014-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0173
Start Marketing Date : 2003-06-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1921
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65085-0026
Start Marketing Date : 2006-04-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12711-9279
Start Marketing Date : 1983-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49452-8113
Start Marketing Date : 1996-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-750
Start Marketing Date : 2015-02-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Verapamil Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Verapamil Hydrochloride, including repackagers and relabelers. The FDA regulates Verapamil Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Verapamil Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Verapamil Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Verapamil Hydrochloride supplier is an individual or a company that provides Verapamil Hydrochloride active pharmaceutical ingredient (API) or Verapamil Hydrochloride finished formulations upon request. The Verapamil Hydrochloride suppliers may include Verapamil Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Verapamil Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Verapamil Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Verapamil Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Verapamil Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Verapamil Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Verapamil Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Verapamil Hydrochloride suppliers with NDC on PharmaCompass.
We have 13 companies offering Verapamil Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
